Class ITerminated in FDA datasetRecall initiated Jun 27, 2012

Standard Process, Pancreatrophin PMG (Product # 6650), 90 Tablets, Proprietary Blend: Bovine…

Recalling firm: Standard Process, Inc.

Why it was recalled

Standard Process, Inc. is voluntarily recalling 3 dietary supplements due to potential Salmonella contamination.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Jan 13, 2014.

Check your package

Compare the exact product and package details with the label you have.

ProductStandard Process, Pancreatrophin PMG (Product # 6650), 90 Tablets, Proprietary Blend: Bovine pancreas PMG extract, dried alfalfa (whole plant) juice, nutritional yeast, porcine duodenum, deflated wheat (gem) , dried buckwheat (leaf) juice and buckwheat (seed). Other Ingredients: Arabic gum and calcium stearate. Standard Process Inc., PO Box 904, Palmyra, WI 59158, UPC 8 12122 01153 2 12.

FDA code information

Lot 114, Best Used By dates of 05/13.

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Standard Process, Pancreatrophin PMG (Product # 6650), 90 Tablets, Proprietary Blend: Bovine pancreas PMG extract, dried alfalfa (whole plant) juice, nutritional yeast, porcine duodenum, deflated wheat (gem) , dried buckwheat (leaf) juice and buckwheat (seed). Other Ingredients: Arabic gum and calcium stearate. Standard Process Inc., PO Box 904, Palmyra, WI 59158, UPC 8 12122 01153 2 12.

Original FDA recall reason

Standard Process, Inc. is voluntarily recalling 3 dietary supplements due to potential Salmonella contamination.

Recall details

Recall number
F-1766-2012
Event ID
62477
FDA status
Terminated
Initiated
Jun 27, 2012
Reported
Jul 25, 2012
Classified
Jul 16, 2012
Terminated
Jan 13, 2014
Quantity
12,422 bottles
Location
Palmyra, WI, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

AL, AZ, AR, CA,CO, CT, DE, DC, FL,GA, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NV, NY, NH,NM, NY, NC, OH, OK, PA, RI,SC, TN,TX,VT, VA, WA, WV, WI.

FDA source record · F-1766-2012

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.